ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,809Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 434

$486K Total Retail Price of All Prescriptions

Rank: 44 out of 434

513 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 513 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 513 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,368 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 729 524 1 2
HYDROCODONE-ACETAMINOPHEN 535 243 S3 2 4
LISINOPRIL 473 315 3 1
AMLODIPINE BESYLATE 471 343 4 6
OMEPRAZOLE 398 262 5 5
LEVOTHYROXINE SODIUM 368 253 6 3
METFORMIN HCL 273 166 7 7
PRAVASTATIN SODIUM 270 228 8 17
ZOLPIDEM TARTRATE 266 159 9 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 240 183 10 21
FLUTICASONE PROPIONATE 220 143 11 26
HYDROCHLOROTHIAZIDE 204 109 12 8
METOPROLOL TARTRATE 199 129 13 12
LOSARTAN POTASSIUM 180 123 14 13
FUROSEMIDE 166 102 15 9
FLUOXETINE HCL 160 65 16 32
METOPROLOL SUCCINATE 151 119 17 22
VENTOLIN HFA 147 98 18 30
LOVASTATIN 142 117 19 10
GABAPENTIN 141 55 20 14
ATENOLOL 137 112 21 16
FAMOTIDINE 128 61 22 76
PANTOPRAZOLE SODIUM 128 56 22 66
CARISOPRODOL 124 30 R 24 44
ATORVASTATIN CALCIUM 120 76 25 19
GLIMEPIRIDE 111 92 26 58
WARFARIN SODIUM 108 88 27 18
MORPHINE SULFATE ER 107 33 S2 28 50
DOXAZOSIN MESYLATE 107 95 28 111
OXYCODONE HCL-ACETAMINOPHEN 105 39 S2 30 53
CARVEDILOL 93 57 31 24
IBUPROFEN 90 26 32 56
ALLOPURINOL 89 63 33 25
AMITRIPTYLINE HCL 80 29 R 34 57
TERAZOSIN HCL 79 69 35 40
OXYCODONE HCL 78 35 S2 36 34
SPIRONOLACTONE 75 43 37 70
NIASPAN 75 50 37 145
TRIAMTERENE-HCTZ 74 54 39 47
SERTRALINE HCL 72 41 40 27
PREDNISONE 71 49 41 42
FENOFIBRATE 71 31 41 43
FINASTERIDE 71 60 41 54
BENAZEPRIL HCL 70 58 44 49
ALENDRONATE SODIUM 68 61 45 15
DIGOXIN 67 48 46 69
TRAMADOL HCL 65 40 47 28
ESTRADIOL 61 52 R 48 73
PAROXETINE HCL 59 47 49 61
PROAIR HFA 59 26 49 60
TAMSULOSIN HCL 56 31 51 29
ADVAIR DISKUS 55 21 52 52
ACTOS 54 42 53 85
BUMETANIDE 50 37 54 165
COMBIVENT 50 28 54 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.